Literature DB >> 31484760

Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.

Yi Zhu1, Chong Li1, Xianzun Tao1, Jennifer M Brazill1, Joun Park1, Zoraida Diaz-Perez1, R Grace Zhai2.   

Abstract

Accumulative aggregation of mutant Huntingtin (Htt) is a primary neuropathological hallmark of Huntington's disease (HD). Currently, mechanistic understanding of the cytotoxicity of mutant Htt aggregates remains limited, and neuroprotective strategies combating mutant Htt-induced neurodegeneration are lacking. Here, we show that in Drosophila models of HD, neuronal compartment-specific accumulation of mutant Htt aggregates causes neurodegenerative phenotypes. In addition to the increase in the number and size, we discovered an age-dependent acquisition of thioflavin S+, amyloid-like adhesive properties of mutant Htt aggregates and a concomitant progressive clustering of aggregates with mitochondria and synaptic proteins, indicating that the amyloid-like adhesive property underlies the neurotoxicity of mutant Htt aggregation. Importantly, nicotinamide mononucleotide adenylyltransferase (NMNAT), an evolutionarily conserved nicotinamide adenine dinucleotide (NAD+) synthase and neuroprotective factor, significantly mitigates mutant Htt-induced neurodegeneration by reducing mutant Htt aggregation through promoting autophagic clearance. Additionally, Nmnat overexpression reduces progressive accumulation of amyloid-like Htt aggregates, neutralizes adhesiveness, and inhibits the clustering of mutant Htt with mitochondria and synaptic proteins, thereby restoring neuronal function. Conversely, partial loss of endogenous Nmnat exacerbates mutant Htt-induced neurodegeneration through enhancing mutant Htt aggregation and adhesive property. Finally, conditional expression of Nmnat after the onset of degenerative phenotypes significantly delays the progression of neurodegeneration, revealing the therapeutic potential of Nmnat-mediated neuroprotection at advanced stages of HD. Our study uncovers essential mechanistic insights to the neurotoxicity of mutant Htt aggregation and describes the molecular basis of Nmnat-mediated neuroprotection in HD.

Entities:  

Keywords:  Huntington’s disease; Nmnat; aggregate; amyloid; mitochondria

Mesh:

Substances:

Year:  2019        PMID: 31484760      PMCID: PMC6754563          DOI: 10.1073/pnas.1904563116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  73 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  A spatial map of olfactory receptor expression in the Drosophila antenna.

Authors:  L B Vosshall; H Amrein; P S Morozov; A Rzhetsky; R Axel
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

3.  Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

Authors:  C A Gutekunst; S H Li; H Yi; J S Mulroy; S Kuemmerle; R Jones; D Rye; R J Ferrante; S M Hersch; X J Li
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  A conditional tissue-specific transgene expression system using inducible GAL4.

Authors:  T Osterwalder; K S Yoon; B H White; H Keshishian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

5.  Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.

Authors:  H Y Chan; J M Warrick; G L Gray-Board; H L Paulson; N M Bonini
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

6.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.

Authors:  P J Muchowski; G Schaffar; A Sittler; E E Wanker; M K Hayer-Hartl; F U Hartl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 7.  Glutamine repeats and neurodegenerative diseases: molecular aspects.

Authors:  M F Perutz
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

8.  Intra- and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases.

Authors:  M Tanaka; I Morishima; T Akagi; T Hashikawa; N Nukina
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

9.  Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.

Authors:  Ivelisse Sánchez; Christian Mahlke; Junying Yuan
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

10.  Polyglutamine protein aggregates are dynamic.

Authors:  Soojin Kim; Ellen A A Nollen; Kazunori Kitagawa; Vytautas P Bindokas; Richard I Morimoto
Journal:  Nat Cell Biol       Date:  2002-10       Impact factor: 28.213

View more
  9 in total

Review 1.  The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions.

Authors:  Carlo Fortunato; Francesca Mazzola; Nadia Raffaelli
Journal:  IUBMB Life       Date:  2021-12-05       Impact factor: 4.709

2.  Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau.

Authors:  Xiaojuan Ma; Yi Zhu; Jinxia Lu; Jingfei Xie; Chong Li; Woo Shik Shin; Jiali Qiang; Jiaqi Liu; Shuai Dou; Yi Xiao; Chuchu Wang; Chunyu Jia; Houfang Long; Juntao Yang; Yanshan Fang; Lin Jiang; Yaoyang Zhang; Shengnan Zhang; Rong Grace Zhai; Cong Liu; Dan Li
Journal:  Elife       Date:  2020-04-06       Impact factor: 8.140

3.  Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington's disease transgenic mouse.

Authors:  Li Niu; Li Li; Shiming Yang; Weixi Wang; Cuifang Ye; He Li
Journal:  Cell Biosci       Date:  2020-09-11       Impact factor: 7.133

4.  Exposure to Aerosolized Algal Toxins in South Florida Increases Short- and Long-Term Health Risk in Drosophila Model of Aging.

Authors:  Jiaming Hu; Jiaqi Liu; Yi Zhu; Zoraida Diaz-Perez; Michael Sheridan; Haley Royer; Raymond Leibensperger; Daniela Maizel; Larry Brand; Kimberly J Popendorf; Cassandra J Gaston; R Grace Zhai
Journal:  Toxins (Basel)       Date:  2020-12-11       Impact factor: 4.546

Review 5.  NAD+ Metabolism and Diseases with Motor Dysfunction.

Authors:  Samuel Lundt; Shinghua Ding
Journal:  Genes (Basel)       Date:  2021-11-09       Impact factor: 4.096

6.  Human Nmnat1 Promotes Autophagic Clearance of Amyloid Plaques in a Drosophila Model of Alzheimer's Disease.

Authors:  Yi Zhu; Amanda G Lobato; R Grace Zhai; Milena Pinto
Journal:  Front Aging Neurosci       Date:  2022-03-24       Impact factor: 5.702

7.  Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.

Authors:  Shengnan Zhang; Yi Zhu; Jinxia Lu; Zhenying Liu; Amanda G Lobato; Wen Zeng; Jiaqi Liu; Jiali Qiang; Shuyi Zeng; Yaoyang Zhang; Cong Liu; Jun Liu; Zhuohao He; R Grace Zhai; Dan Li
Journal:  Elife       Date:  2022-09-01       Impact factor: 8.713

Review 8.  Modeling Neurodegenerative Disorders in Drosophila melanogaster.

Authors:  Harris Bolus; Kassi Crocker; Grace Boekhoff-Falk; Stanislava Chtarbanova
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 9.  Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.

Authors:  Lalitha Venkataraman; Summer R Fair; Craig A McElroy; Mark E Hester; Hongjun Fu
Journal:  Stem Cell Rev Rep       Date:  2020-11-12       Impact factor: 6.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.